Chakravarty, Sarvajit,Rai, Roopa,Pham, Son Minh,Pujala, Brahmam,Jangir, Ramniwas,Guguloth, Rambabu,Sharma, Vijay Kumar
申请号：
AU2014312245
公开号：
AU2014312245B2
申请日:
2014.08.28
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
This disclosure provides compounds and methods of using those compounds to treat metabolic disorders and hyperproliferative disorders, including administration of the compounds in conjunction with hormone receptor antagonists. Compounds of the invention may also find use in treating cancer. Presented herein are novel compounds bearing a perhaloalkylsulfonamide moiety. Such compounds, in addition to being highly effective SREBP inhibitors, are also unexpectedly highly bioavailable in vivo. Heteroaromatic compounds bearing sulfonamide groups are prone to several ionic states, based on the inherent pKa values.
